Marcos A Prono, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |
Jacquelin Nickole Psota, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 614 Merchant St, Emporia, KS 66801 Phone: 620-794-8616 |
Drucilla Antony Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 |
Saman Mehak Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 |
Angela B Martinez, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 |
Eric Michael Sears Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |
Jason A Eberle, LMLP Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |
Michelle Ferrer, LMLP Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 785-249-6697 |
Dr. Robyn Elizabeth Long, PH.D. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 1420 C Of E Dr, Suite 115, Emporia, KS 66801 Phone: 706-372-2554 |
Amanda J Cunningham, LMLP Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 |
Rebecca L Maltby, LMLP Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |
Audrey Warrington, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1221 E 12th Ave, Emporia, KS 66801 Phone: 785-825-0541 |
Angie C Indra Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |
Sally J Harman, LCP Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |
Megan M Adcock, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |
Ms. Carolyn R Martin, MS,LMLP,LCP,AAPS,RAO Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |
Dacey Jo Telfer Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |
Jim Dow Persinger Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 1 Kellogg Cir, Emporia, KS 66801 Phone: 620-341-5317 |
Katey Elizabeth Staatz Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |
Anja D Ford, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 |
News Archive
It certainly makes sense: COPD sufferers have varying degrees of serious breathing difficulties, which keeps them from almost any kind of exercise, especially in advanced stages. So maybe "lighter than air" air would be easier to breath, reduce shortness of breath and perhaps even allow them to do some exercise with all of its physical and mental benefits.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-PCS, an RNAi therapeutic for the treatment of severe hypercholesterolemia.
Follow-Up Study Published in the Journal of Parkinson's Disease Supports an Earlier "Proof of Concept" Trial. A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy.
As COVID-19 cases continue to climb, front-line health care workers are decrying unsafe working conditions — in particular, describing inadequate access to personal protective equipment, or PPE.
› Verified 3 days ago